{
    "organizations": [],
    "uuid": "e4b64a284a220beabe06909cf02327910ad7dbd1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ait-therapeutics-announces-further/brief-ait-therapeutics-announces-further-data-from-its-no-ntm-abscessus-phase-2-clinical-trial-idUSASB0C1OI",
    "ord_in_thread": 0,
    "title": "AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 20 PM / Updated 17 minutes ago BRIEF-AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial Reuters Staff 1 Min Read \nJan 22 (Reuters) - Ait Therapeutics Inc: \n* AIT THERAPEUTICS ANNOUNCES FURTHER DATA FROM ITS NO-NTM ABSCESSUS PHASE 2 CLINICAL TRIAL IN NONTUBERCULOUS MYCOBACTERIA (NTM) PATIENTS  ",
    "published": "2018-01-22T21:20:00.000+02:00",
    "crawled": "2018-01-22T15:32:35.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "announces",
        "data",
        "abscessus",
        "phase",
        "clinical",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "ait",
        "therapeutic",
        "inc",
        "ait",
        "therapeutic",
        "announces",
        "data",
        "abscessus",
        "phase",
        "clinical",
        "trial",
        "nontuberculous",
        "mycobacteria",
        "ntm",
        "patient"
    ]
}